BOLZANO, Italy, December 1 /PRNewswire/ --     Health Robotics and Devon International Group (DIG) today announced their
plans to kick-off the launch of the i.v.STATION(TM) Robot with a prototype
demonstration at the American Society of Health-System Pharmacists Midyear
Meeting in Orlando, Florida [Booth 1307], and the simultaneous start of 12
i.v.STATION(TM) Beta Installations for market validation and testing around
the world.

The primary challenges in today's IV Admixture operations are serious
medication errors, high costs, turn-around time, waste, regulatory issues,
lack of audit trails, motion injuries, space constraints and difficulty in
maintaining adequate and trained staff. i.v.STATION(TM) was designed to
address these issues and overcome the fact that until now, the range of
products and technology available to mitigate these challenges has consisted
of variations on the IV "piggyback" bag, outsourcing of IVs, and partial
robotic solutions that have seen very limited adoption and success over the
past decade. i.v.STATION(TM) represents a revolutionary approach in the quest
for safe, accurate, efficient, and cost effective IV Admixtures. It offers
unprecedented IV container flexibility, life-critical patient safety, and
robotic precision and performance, all within a scalable and fail-safe
architecture.

"In the wake of prominent IV Solutions and Pharmacy Automation companies'
[B|Braun, TOSHO, AHCSC-Olayan, & Can-Med's] due diligence and endorsement of
Health Robotics' products, DIG started to study the market and existing
technology in the IV sector in March 2008, with visits to multiple Health
Robotics' customers, factories, and R&D laboratories in the United States,
Europe, and Asia-Pacific. I have personally witnessed how i.v.STATION(TM), at
20-25% of the cost, 5-10% of the footprint, and comparable throughput of
other IV automation solutions in this space can truly expand Health Robotics'
sole leadership position with CytoCare(TM) beyond Oncology and Immunology
into assuring that virtually all dispensed IVs and Epidurals are safe,
sterile, accurate, ready-to-administer, and cost effective," stated John
Bennett, MD, DIG's CEO.

i.v.STATION(TM) may be deployed in a variety of locations, including
central and satellite pharmacies and patient care areas, due to its
self-contained form and small "foot print". Pharmacies may, for the first
time, choose a robotic configuration that suits their needs, rather than
being forced into the dated alternative of "one-size-fits-all" robots.
Whether a Pharmacy chooses single or multiple i.v.STATION(TM) configurations,
it will benefit from fully automated compounding while producing its
patient-specific or batch IV doses in a variety of syringe (1 to 60cc), bag
(50ml to 1 liter), and vial (1 to 100ml) sizes. Furthermore, i.v.STATION(TM)
supports "just-in-time IV filling", avoiding premium prices associated with
specialty & pre-filled bags and syringes and high cost closed-system-transfer
devices.

Health Robotics has reached agreements for upcoming i.v.STATION(TM)
installations to "go-live" and deliver non-hazardous IV doses to patients at
the University of Texas' M.D. Anderson Cancer Center (Houston), Fairview
Pharmacy Services & University of Minnesota Children's Hospital
(Minneapolis), University of Colorado (Denver), Allegiance Health (Jackson,
Michigan), Imperial College Healthcare NHS Trust (University of London, UK),
King Faisal Specialist Hospital & Research Centre (Riyadh, Saudi Arabia),
Kameda Medical Center (Japan), Dubai Health Authority (Dubai, UAE), Agean
University Hospital (Izmir, Turkey), Tawam Hospital-a Johns Hopkins Medicine
Affiliate (Abu Dhabi, UAE), Bozen Krankenhaus (Bozen, Italy) & Campus
Biomedico University Hospital (Rome, Italy).

"The strategic partnership between Health Robotics and Devon is quickly
paying off as evidenced by the recent addition of several renowned American
hospitals to other i.v.STATION(TM) Beta installations around the world. I am
very pleased with the prestige and diversity of the hospital pharmacists that
have chosen to partner with Health Robotics in North America for the purpose
of validating with "live" patient IV Admixtures our new non-hazardous-IVs
Robot's features, functions, and R.O.I. model. After developing the only
existing hazardous IV Robot [CytoCare(TM)], we have now leapfrogged the
competition in non-hazardous IV Robotics as well. I look forward to meeting
these pharmacists at the Beta Kickoff in Orlando on December 9th, where Paolo
Giribona and Gaspar DeViedma, the two architects behind i.v.STATION(TM) will
kick-off the installation process. The upcoming i.v.STATION(TM) installations
in America represent a great mix of hospitals [academic and community,
general and oncology, adult and pediatric] and even a centralized compounding
service" stated Werner Rainer, Health Robotics' CEO.

This simultaneous global launch is a testament to Health Robotics defying
the conventional wisdom that a start-up technology company in the healthcare
sector cannot leave its competitors behind in less than 2 years. Health
Robotics will complete its i.v.STATION(TM) strategic partners' line-up over
the next 60 days after the conclusion of ongoing technical due diligence and
financial negotiations with multiple healthcare companies in Europe, Asia,
Oceania, and Latin America, some of which will take place during ASHP. The
Beta installations will be key in assuring that Health Robotics can deliver a
mature, feature-rich, flexible, and cost-effective product to the more than
750 i.v.STATION(TM) purchase orders the company has registered from all over
the world.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical
intra-venous medication preparation, compounding, and dispensing Robots,
providing health care facilities around the world with robotic technology and
software automation solutions. The world-leading solutions CytoCare(TM)
[hazardous IVs] and i.v.STATION(TM) [non-hazardous IVs] have and will greatly
contribute to ease global hospitals' & clinics' growing pressures to improve
patient safety through effective and efficient production of sterile,
accurate, and ready-to-administer IVs, to decrease life-threatening
medication errors and contamination risks, and to work more efficiently,
increase throughput, reduce waste, and contain spiraling costs.

About Devon International Group

The Devon International Group (DIG) is a multi-national group of
companies headquartered in King of Prussia, Pennsylvania, spanning the
healthcare, information technology, and international business industries.
Its flagship companies includes Devon Health Services, a national healthcare
cost management company and the largest privately held Preferred Provider
Organization (PPO) in the Northeast U.S., Devon IT, the world's third largest
manufacturer of thin clients, Devon Medical, and Devon Robotics.

For additional information, please contact:
    Health Robotics
    Gaspar G. DeViedma
    USA: +1-609-980-7976
    EUROPE: +39-346-963-4934
    gaspar.deviedma@health-robotics.com